Schedule 13G ownership disclosure

ONCOCYTE CORPORATION

Security class unavailable · CUSIP: 68235C107

Event date: 2021-01-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-21-001984
Form type
SC 13G/A
Filer
Insight Molecular Diagnostics Inc.
CIK
CIK 1642380
Filed
Jan 28, 2021
Reporting period
Jan 20, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub